TY  - JOUR

T1  - 1052 Cost-effectiveness of epoetin alfa (EPO) and darbepoetin alfa (DARB) based on hematopoietic response rates and cost of therapy

JO  - European Journal of Cancer Supplements

PY  - 2003/09/05

AU  - Van Hout B

AU  - Gagnon D

AU  - Guastalla J-P

ED  - 

DO  - DOI: 10.1016/s1359-6349(03)91078-0

PB  - Elsevier BV

VL  - 1

IS  - 5

SP  - S313

EP  - S314

Y2  - 2024/12/22

ER  -